# Catalent Pharma Solutions, LLC - Inspection Records

Source: https://www.keypedia.com/companies/catalent-pharma-solutions-llc/12f42026-6a34-4cfe-936d-3646a0e34c8d

> Inspection records and compliance data for Catalent Pharma Solutions, LLC in Winchester, Kentucky. Access full analysis and detailed observations.

---

## Details

- Name: Catalent Pharma Solutions, LLC
- FEI Number: 1000122400
- City: Winchester
- State: Kentucky
- Country Name: United States
- Address Line 1: 1100 Enterprise Dr
- Zip Code: 40391
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK

## Related Documents

- [483 - Catalent Pharma Solutions, LLC - 2025-04-22](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/8fba6d96-b5ce-4dd0-9801-cdd4fe61f210) — source: FDA, date: April 22, 2025
- [FDA Inspection 1264863 - Catalent Pharma Solutions, LLC - 2025-04-22](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/75d3b7af-af79-4201-8c16-7d0ab25403b1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 22, 2025
- [483 - Catalent Pharma Solutions, LLC - 2023-01-11](https://www.keypedia.com/records/483/catalent-pharma-solutions-llc/ea296a40-d7a3-4254-8f00-4c9ad8e69edf) — source: FDA, date: January 11, 2023
- [FDA Inspection 1195321 - Catalent Pharma Solutions, LLC - 2023-01-11](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/a63496e0-06b4-457e-9223-d009f682460f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 11, 2023
- [EIR - Catalent Pharma Solutions, LLC - 2021-08-02](https://www.keypedia.com/records/eir/catalent-pharma-solutions-llc/98b0b456-4bf9-4429-aff1-87c329d4c785) — source: FDA, date: August 2, 2021
- [FDA Inspection 1038136 - Catalent Pharma Solutions, LLC - 2017-11-15](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/4b0f46d0-1779-4bf0-9892-0afc8ab0e7c4) — classification: No Action Indicated (NAI), source: FDA, date: November 15, 2017
- [FDA Inspection 1012414 - Catalent Pharma Solutions, LLC - 2017-05-04](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/8e27ebd5-0aca-4ba0-a816-f387431bfc2b) — classification: No Action Indicated (NAI), source: FDA, date: May 4, 2017
- [FDA Inspection 885092 - Catalent Pharma Solutions, LLC - 2014-06-27](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/0fa3e6ad-5c8e-418d-8a86-0d2cdf63a509) — classification: No Action Indicated (NAI), source: FDA, date: June 27, 2014
- [FDA Inspection 820796 - Catalent Pharma Solutions, LLC - 2013-02-05](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/4ed2453b-7360-4ed1-b8ab-47a906c42715) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 5, 2013
- [FDA Inspection 810206 - Catalent Pharma Solutions, LLC - 2012-11-14](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/d612136f-011f-4347-90df-487b5555e1c1) — classification: No Action Indicated (NAI), source: FDA, date: November 14, 2012
- [FDA Inspection 779004 - Catalent Pharma Solutions, LLC - 2012-04-19](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/1c5d9cd8-be44-4475-9d67-a0afd70a7568) — classification: No Action Indicated (NAI), source: FDA, date: April 19, 2012
- [FDA Inspection 722291 - Catalent Pharma Solutions, LLC - 2011-04-21](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/2147b0e5-c2ac-459c-95c4-d3d9e056b2f9) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2011
- [FDA Inspection 556932 - Catalent Pharma Solutions, LLC - 2008-12-09](https://www.keypedia.com/records/fda_inspections/catalent-pharma-solutions-llc/d4e806c8-cb13-4046-8248-efe9721495e6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 9, 2008

## Related Companies

- [Lyne Laboratories, Inc.](https://www.keypedia.com/companies/lyne-laboratories-inc/47a79cbe-dd2e-43d9-bf70-129caae3817c)
- [Abraxis Bioscience, LLC](https://www.keypedia.com/companies/abraxis-bioscience-llc/5751a531-276f-4635-9289-30cacf498d86)
- [DPT Laboratories, Ltd](https://www.keypedia.com/companies/dpt-laboratories-ltd/0a6b4d0a-ad7e-4f4f-ab10-34e0ef9913d4)
- [Ultradent Products, Inc.](https://www.keypedia.com/companies/ultradent-products-inc/16b4d8af-54bd-48d3-acc8-a5169bd5bfe3)
- [Bristol-Myers Squibb Holdings Pharma Ltd. Liability Company](https://www.keypedia.com/companies/bristol-myers-squibb-holdings-pharma-ltd-liability-company/64a65e7b-7328-491c-8b08-cc8f2e018968)
- [Bushu Pharmaceuticals Ltd.](https://www.keypedia.com/companies/bushu-pharmaceuticals-ltd/f3ccab51-b6fa-4873-b2de-61ba32d7967e)
- [Laboratorios Liconsa SAU](https://www.keypedia.com/companies/laboratorios-liconsa-sau/ab88a2bb-8c52-445d-8417-82ea8f48bdf6)
- [WES Pharma Inc.](https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d)
- [AMO (Hangzhou) Co., Ltd.](https://www.keypedia.com/companies/amo-hangzhou-co-ltd/00c065f6-3b50-4050-811e-d03ad3d646e9)
- [King Pharmaceuticals LLC](https://www.keypedia.com/companies/king-pharmaceuticals-llc/d90c79dd-4325-4185-bf42-87c7f116f6c5)

## Related Officers

- [Investigator ](https://www.keypedia.com/people/logan-t-williams/a1febf59-970a-4e4e-9c0c-f4ad385582d7)
- [Mathematical statistician](https://www.keypedia.com/people/wen-ning-chan/e1f71810-6994-4474-876f-699ea9dee32c)
- [General Manager](https://www.keypedia.com/people/christopher-m-rosenbaum/ab4a60e4-e0fd-422e-b613-ceaf255cad7e)
- [investigator](https://www.keypedia.com/people/geoffrey-k-kilili/b00aeedf-95bd-4ccf-a23e-6e12e60249c4)